BNTX
BNTX
US09075V1026
BioNTech SE
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 60/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±52.4% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.3x as much as the broader market.

Beta (Market Relation)
1.25x
Above average
Volatility (5Y p.a.)
52.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-78.4%
5-Year Horizon
Sharpe Ratio
-0.39
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -13.4%
3 Years 46.2% -33.9% -0.17 -5.6%
5 Years 52.4% -78.4% -0.39 -17.8%
10 Years — — — —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (52.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -78.4% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
1 ISS Score: 1 / 10
Board Risk
4 ISS Score: 4 / 10
Short Ratio
1.35
ende